Variables | Control (n = 49) | Adverse outcome (n = 25) | p |
---|---|---|---|
Age, y, mean | 67.98 ± 12.02 | 61.80 ± 14.94 | 0.058b |
Gender, male | 29(59.2) | 18(72.0) | 0.318 a |
Prior DVT | 5(10.2) | 4(16.0) | 0.476 a |
Previous surgery/trauma | 9(18.4) | 9(36.0) | 0.151 a |
Previous tumour | 3(6.12) | 1(4.0) | 0.703a |
Smoking | 9(18.4) | 6(24.0) | 0.559 a |
Previous COPD | 6(12.2) | 1(4.0) | 0.411 a |
Hypertension | 24(49.0) | 13(52.0) | 0.806a |
Diabetes mellitus | 6(12.2) | 5(20.0) | 0.492 a |
Previous CAD | 9(18.4) | 2(8.0) | 0.314 a |
Bp(systolic) < 100 mmHg | 5(10.2) | 6(24.0) | 0.167a |
SaO2 < 90% | 8(16.3) | 10(40.0) | 0.043 a |
Thrombolytic therapy | 6(12.2) | 14(56.0) |  < 0.010 a |
Major bleeding requiring transfusion | 0(0) | 2(8.0) | 0.111 a |
RV/LV ratio | 1.17 ± 0.48 | 1.51 ± 0.52 | 0.006b |
Syncope | 4(8.2) | 7(28.0) | 0.039 a |
Intermediate high risk | 25(51.0) | 20(80.0) | 0.023 a |
Tachycardia | 22(44.9) | 16(64.0) | 0.145 a |
S1Q3T3 | 10(20.4) | 8(32.0) | 0.39 a |
RBBB | 10(20.4) | 3(12.0) | 0.523 a |
Atrial fibrillation or flutter | 3(6.12) | 1(4.0) | 0.703 a |
Qr in V1 | 5(10.2) | 2(8.0) | 0.759a |
NTW in V1–V3 | 8(16.3) | 12(48.0) | 0.006 a |
QTc prolongation | 16(32.7) | 13(52.0) | 0.134 a |
Clockwise rotation | 4(8.2) | 6(24.0) | 0.078 a |
WBC, × 109/L | 7.60(5.85–8.95) | 10.30(8.30–13.30) | 0.000 c |
Haemoglobin, g/L | 126.08 ± 19.10 | 123.48.10 ± 22.52 | 0.604b |
BNP, pg/mL | 393.25 ± 374.87 | 648.66 ± 478.70 | 0.014b |
D-dimer,ug/mL | 4.90(3.35–7.16) | 6.08(4.13–17.11) | 0.315 c |
Troponin I positive | 44(89.7) | 22(88.0) | 0.814 a |
Serum Creatinine, umol/L | 70.6(62.80–97.90) | 66.0(55.70–77.25) | 0.177 c |
Length of hospital stay, days | 11(9–13) | 12(9.5–13.5) | 0.094 c |